Liquid Biopsy cfDNA EGFR Test
Revolutionary Non-Invasive Cancer Detection
The Liquid Biopsy cfDNA EGFR Test represents a groundbreaking advancement in cancer diagnostics, offering a minimally invasive alternative to traditional tissue biopsies. This innovative test analyzes circulating tumor DNA (ctDNA) from a simple blood draw, providing crucial genetic information about EGFR mutations that drive cancer progression in lung and colorectal malignancies.
What is Liquid Biopsy Technology?
Liquid biopsy technology detects cancer-related genetic alterations by analyzing cell-free DNA (cfDNA) released into the bloodstream by tumor cells. Unlike conventional tissue biopsies that require invasive procedures, liquid biopsy offers a safer, more convenient approach to cancer monitoring and treatment selection.
What the Test Detects
Our advanced Liquid Biopsy cfDNA EGFR Test specifically targets three critical EGFR mutations:
- p.E746_A750 deletion – A common EGFR mutation in non-small cell lung cancer
- p.T790M mutation – Associated with resistance to first-generation EGFR inhibitors
- p.L858R mutation – A primary activating mutation in EGFR-driven cancers
Who Should Consider This Test
Primary Candidates Include:
- Patients diagnosed with non-small cell lung cancer (NSCLC)
- Individuals with colorectal cancer showing EGFR pathway involvement
- Patients experiencing progression on current EGFR-targeted therapies
- Those requiring treatment monitoring without invasive procedures
- Individuals with contraindications for tissue biopsy
- Patients seeking comprehensive mutation profiling for personalized therapy
Clinical Indications:
- Initial diagnosis and mutation profiling
- Treatment response monitoring
- Detection of acquired resistance mutations
- Disease progression assessment
- Therapy selection guidance
Key Benefits of Liquid Biopsy Testing
Patient-Centered Advantages:
- Non-Invasive Procedure – Simple blood draw eliminates surgical risks
- Comprehensive Monitoring – Track treatment response over time
- Early Detection – Identify resistance mutations before clinical progression
- Personalized Treatment – Guide targeted therapy selection
- Reduced Hospital Visits – Convenient testing without complex procedures
- Real-Time Insights – Monitor tumor dynamics throughout treatment
Understanding Your Test Results
Interpretation Guidelines:
Your test results will provide detailed information about the presence or absence of specific EGFR mutations. A positive result indicates the detection of targeted mutations, which may guide treatment decisions with EGFR inhibitors. Negative results suggest the absence of tested mutations, potentially indicating alternative treatment pathways.
Clinical Implications:
- Positive for EGFR mutations: May benefit from targeted EGFR inhibitor therapy
- Detection of T790M mutation: Suggests resistance to first-line EGFR inhibitors
- Negative results: Consider alternative treatment strategies
- Quantitative changes: Monitor treatment response and disease progression
Test Specifications and Pricing
| Test Component | Details |
|---|---|
| Test Name | Liquid Biopsy cfDNA EGFR Test |
| Regular Price | $626 USD |
| Discount Price | $520 USD |
| Sample Type | 10 mL whole blood in 1 Streck tube |
| Shipping Requirements | Ship refrigerated. DO NOT FREEZE |
| Turnaround Time | Sample Mon/Thu by 9 am; Report Fri/Tue |
| Testing Method | Droplet Digital PCR |
| Clinical Requirement | Clinical history is mandatory |
Nationwide Availability
We have branches across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our comprehensive network ensures convenient access to advanced cancer diagnostics nationwide.
Take Control of Your Cancer Journey
Don’t wait to get the critical genetic information you need for personalized cancer treatment. Our Liquid Biopsy cfDNA EGFR Test provides the insights necessary to make informed treatment decisions and monitor your response to therapy.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our dedicated team is available to answer your questions and guide you through the testing process.
Take the first step toward personalized cancer care with our advanced liquid biopsy technology. Your journey to better cancer management starts with a simple blood test.
